This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Erythromycin

Read time: 1 mins
Marketing start date: 26 Nov 2024

Summary of product characteristics


Effective Time

20231026

Version

2

Spl Product Data Elements

Erythromycin Erythromycin ERYTHROMYCIN ERYTHROMYCIN MINERAL OIL PETROLATUM

Brand Name

Erythromycin

Generic Name

Erythromycin

Product Ndc

48102-057

Product Type

HUMAN PRESCRIPTION DRUG

Route

OPHTHALMIC

Package Label Principal Display Panel

Principal Display Panel - 5 mg Carton Label (Steri-Med) Sterile Sterile 50 x 1g unit dose tubes tubes unidose DIN 02326663 Pr ONGUENT OPHTALMIQUE D'ERYTHROMYCINE USP Pr ERYTHROMYCIN OPHTHALMIC OINTMENT USP 5 MG/G ANTIBIOTIC / ANTIBIOTIQUE Steri-Med Pharma Principal Display Panel - 5 mg Carton Label (Steri-Med)

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.